Microangiopathy in Diabetes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorKarolinska Institutet

About this trial

This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.

Eligibility criteria

Qualifiers

Diabetes mellitus type 1.

Cohort specific inclusion criteria apply, please review 'groups' section.

Disqualifiers

Patients unable to understand patient information due to cognitive impairment.

Patients unable to understand patient information due to language barriers.

Ongoing acute infection disease or inflammatory condition.

Pregnant or breast-feeding women.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 4 trial groups

Sponsors and collaborators

Karolinska Institutet

Lead sponsor

Neko Health AB

Collaborator